Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Critical Care
Volume 2011 (2011), Article ID 824639, 4 pages
http://dx.doi.org/10.1155/2011/824639
Case Report

Multiple Transverse Colonic Perforations Associated with Slow-Release Nonsteroidal Anti-Inflammatory Drugs and Corticosteroids: A Case Report

Department of Critical Care and Emergency, Iwate Prefectural Advanced Critical Care and Emergency Center, Iwate Medical University, 19-1 Uchimaru, Morioka 020-8505, Japan

Received 22 May 2011; Accepted 22 June 2011

Academic Editors: A. Banga and M. Doganay

Copyright © 2011 Nobuki Shioya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Wallaert, J. F. Colombel, A. Adenis et al., “Increased intestinal permeability in active pulmonary sarcoidosis,” American Review of Respiratory Disease, vol. 145, no. 6, pp. 1440–1445, 1992. View at Google Scholar · View at Scopus
  2. P. A. McCormick, D. P. O'Donoghue, and M. X. FitzGerald, “Crohn's colitis and sarcoidosis,” Postgraduate Medical Journal, vol. 62, no. 732, pp. 951–953, 1986. View at Google Scholar · View at Scopus
  3. C. Kara, H. Derici, O. NazlI, T. Tansug, and A. D. Bozdag, “Colonic perforation after short-term use of nonsteroidal antiinflammatory drugs: report of two cases,” Techniques in Coloproctology, vol. 13, no. 1, pp. 75–78, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. L. Schiffmann, S. Kahrau, G. Berger, and H. J. Buhr, “Colon perforation in an adolescent after short-term diclofenac intake,” ANZ Journal of Surgery, vol. 75, no. 8, pp. 726–727, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. S. Somasundaram, G. Sigthorsson, R. J. Simpson et al., “Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat,” Alimentary Pharmacology and Therapeutics, vol. 14, no. 5, pp. 639–650, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Sakaguchi, S. Brand, and H. C. Reinecker, “Mucosal barrier and immune mediators,” Current Opinion in Gastroenterology, vol. 17, no. 6, pp. 573–577, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. K. R. Groschwitz and S. P. Hogan, “Intestinal barrier function: molecular regulation and disease pathogenesis,” Journal of Allergy and Clinical Immunology, vol. 124, no. 1, pp. 3–20, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. J. V. Willis, M. J. Kendall, and D. B. Jack, “The influence of food on the absorption of diclofenac after single and multiple oral doses,” European Journal of Clinical Pharmacology, vol. 19, no. 1, pp. 33–37, 1981. View at Google Scholar · View at Scopus
  9. H. Imaeda, H. Ishii, and M. Goto, “Treatment of peptic ulcer related to rheumatic diseases,” Nippon Rinsho, vol. 60, no. 8, pp. 1585–1591, 2002. View at Google Scholar · View at Scopus
  10. A. Lanas, “Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding,” Italian Journal of Gastroenterology and Hepatology, vol. 31, no. 1, pp. S37–S42, 1999. View at Google Scholar · View at Scopus
  11. G. Börsch and G. Schmidt, “What's new in steroid and nonsteroid drug effects on gastroduodenal mucosa?” Pathology Research and Practice, vol. 180, no. 4, pp. 437–444, 1985. View at Google Scholar · View at Scopus
  12. C. R. Morris, I. M. Harvey, W. S. L. Stebbings, C. T. M. Speakman, H. J. Kennedy, and A. R. Hart, “Epidemiology of perforated colonic diverticular disease,” Postgraduate Medical Journal, vol. 78, no. 925, pp. 654–659, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Mpofu, C. M. A. Mpofu, D. Hutchinson, A. E. Maier, S. R. Dodd, and R. J. Moots, “Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions,” Annals of the Rheumatic Diseases, vol. 63, no. 5, pp. 588–590, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. F. L. Lanza, F. K. L. Chan, E. M. M. Quigley et al., “Guidelines for prevention of NSAID-related ulcer complications,” American Journal of Gastroenterology, vol. 104, no. 3, pp. 728–738, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. J. R. Curtis, F. Xie, L. Chen et al., “The incidence of gastrointestinal perforations among rheumatoid arthritis patients,” Arthritis and Rheumatism, vol. 63, no. 2, pp. 346–351, 2011. View at Publisher · View at Google Scholar · View at PubMed
  16. M. J. S. Langman, L. Morgan, and A. Worrall, “Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage,” British Medical Journal, vol. 290, no. 6465, pp. 347–349, 1985. View at Google Scholar · View at Scopus
  17. M. Catanoso, R. Lo Gullo, M. R. Giofré et al., “Gastro-intestinal permeability is increased in patients with limited systemic sclerosis,” Scandinavian Journal of Rheumatology, vol. 30, no. 2, pp. 77–81, 2001. View at Publisher · View at Google Scholar
  18. I. Fresko, V. Hamuryudan, M. Demir et al., “Intestinal permeability in Behçet's syndrome,” Annals of the Rheumatic Diseases, vol. 60, no. 1, pp. 65–66, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Picco, M. Gattorno, N. Marchese et al., “Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters,” Clinical and Experimental Rheumatology, vol. 18, no. 6, pp. 773–778, 2000. View at Google Scholar · View at Scopus
  20. A. Farhadi, A. Banan, J. Fields, and A. Keshavarzian, “Intestinal barrier: an interface between health and disease,” Journal of Gastroenterology and Hepatology, vol. 18, no. 5, pp. 479–497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Lindgren, C. P. Engstrom, O. Nilsson, and H. Abrahamsson, “Protein-losing enteropathy in an unusual form of sarcoidosis,” European Journal of Gastroenterology and Hepatology, vol. 7, no. 10, pp. 1005–1007, 1995. View at Google Scholar · View at Scopus
  22. G. W. Hunninghake, U. Costabel, M. Ando et al., “Statement on sarcoidosis,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 736–755, 1999. View at Google Scholar
  23. P. Brito-Zerón, M. Ramos-Casals, A. Bove, J. Sentis, and J. Font, “Predicting adverse outcomes in primary Sjögren's syndrome: identification of prognostic factors,” Rheumatology, vol. 46, no. 8, pp. 1359–1362, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. M. Inoh, M. Tokuda, T. Maruoka et al., “Multiple colonic ulcers in a patient with Sjogren's syndrome,” Ryumachi, vol. 35, no. 3, pp. 585–588, 1995. View at Google Scholar · View at Scopus